Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva santé animale - inaktiveeritud coxiella burnetii vaktsiin, üheksa miili tüvi - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antitrombootilised ained - prevention of venous thromboembolic events.

Euroopa Liit - eesti - EMA (European Medicines Agency)

intervet international b.v. - raku seotud live rekombinantse türgi herpesvirus (tüvi hvt/ilt-138), mis väljendavad glycoproteins gd ja gi nakkav viirus laryngotracheitis - immunoloogilised ravimid jaoks linnud, live viral vaccines - kana - aktiivse immuniseerimise ühe-päeva-tibusid, et vähendada suremust, kliinilisi tunnuseid ja kahjustused nakatumine lindude nakkav laryngotracheitis (ilt) viirus ja marek tõbi (md) viirus.

Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - kana - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Euroopa Liit - eesti - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunoloogilised ained - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Euroopa Liit - eesti - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Eesti - eesti - Ravimiamet

boehringer ingelheim international gmbh - dekstrometorfaan - siirup - 10mg 5ml 200ml 1tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - dabigatraaneteksilaat - kõvakapsel - 110mg 100tk; 110mg 10tk; 110mg 60tk; 110mg 180tk; 110mg 30tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - dabigatraaneteksilaat - kõvakapsel - 150mg 10tk; 150mg 180tk

Eesti - eesti - Ravimiamet

viatris limited - dabigatraaneteksilaat - kõvakapsel - 110mg 180tk